Lv3
330 积分 2026-01-12 加入
PIK3CA-Mutated Breast Cancer: From Biology to Targeted Therapy and Beyond
1个月前
已关闭
Genomics to select treatment for patients with metastatic breast cancer
1个月前
已完结
Targeting PI3K inhibitor resistance in breast cancer with metabolic drugs
1个月前
已完结
Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study
1个月前
已完结
Overall Survival with Inavolisib in PIK3CA-Mutated Advanced Breast Cancer
1个月前
已完结
Combination of autophagy inhibitors with high-dose CDK4/6 inhibitors offers new hope for advanced HR+/HER2- breast cancer
1个月前
已关闭
Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies
2个月前
已完结
Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer
2个月前
已完结
MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer
2个月前
已完结
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial
2个月前
已完结
皖公网安备34019202002308
